University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green Daridorexant  (QUVIVIQ®)
Status: Red Dasatinib tablets

Hospital use only

Status: Red Deep Blue®

Lifting agent for use during complex EMR/ESD procedures

Status: Red Deferiprone tablets (Ferriprox)

NHSE commissioned.

Status: Amber Degarelix injection

Supported by ESCA

Status: Amber Demeclocycline capsules

For the treatment of hyponatraemia resulting from inappropriate secretion of antidiuretic hormone. Unlicensed.

Status: Amber Denosumab injection (Prolia®)

ESCA

Status: Amber Dermatonics Once Heel Balm®

Specialist recommendation for epidermolysis bullosa and diabetes patients only

Status: Green Dermol 500 lotion

Short term use only

Status: Red Desferrioxamine injection

NHSE commissioned - NICE NG8.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top